After 30 days on the 1.5 mg dose, increase the dose to 4 mg once daily
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
Originally prescribed to treat people with type 2 diabetes, GLP-1 drugs are now being used to treat obesity and a variety of other medical conditions
We surveyed 1,022 current or recent GLP-1 users to explore how GLP-1 medications may influence habits related to substance use, impulse control, and daily routines
A $79/mo membership fee sits on top of every medication, prices for branded GLP-1s and microdose compounded options are hidden until a patient formally requests them, and the headline marketing rate of $39 reflects the membership only, not the full cost of starting treatment
Gastroparesis: current diagnostic challenges and management considerations